Back to Search
JOHN ANG, MD
MD
General Practice Physician
NPI: 1326196114Individual
Specialties, Licenses & Credentials
Body Imaging Physician
Radiology — Body Imaging
Code: 2085B0100X
A42727(CA)
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
A42727(CA)
Research & Publications (20)
Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin.
PMID 18414152·South Med J·2008
5-case
The discriminative power of the Wolf motor function test in assessing upper extremity functions in persons with stroke.
PMID 17106357·Int J Rehabil Res·2006
8-other
Use of complementary and alternative medicine by parents of children with HIV infection and asthma and well children.
PMID 16217978·South Med J·2005
4-observational
CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator?
PMID 15533898·Cancer Epidemiol Biomarkers Prev·2004
8-other
Appraisal underpinnings of affective chronometry: the role of appraisals in emotion habituation.
PMID 19558441·J Pers·2009
8-other
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.
PMID 19542250·Ann Oncol·2009
3-trial
Origins of the new influenza A(H1N1) virus: time to take action.
PMID 19497253·Euro Surveill·2009
8-other
Driving behaviors among community-dwelling persons with multiple sclerosis.
PMID 19480873·Arch Phys Med Rehabil·2009
8-other
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
PMID 19401696·Br J Cancer·2009
8-other
Prospective validation of a prognostic score to improve patient selection for oncology phase I trials.
PMID 19332724·J Clin Oncol·2009
4-observational
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer.
PMID 19223900·Br J Cancer·2009
6-review
Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge.
PMID 19124600·Infect Immun·2009
7-preclinical
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.
PMID 18695026·Ann Oncol·2009
8-other
90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?
PMID 18550361·Eur J Cancer·2008
4-observational
Dissecting prostate carcinogenesis through ETS gene rearrangement studies: implications for anticancer drug development.
PMID 18495790·J Clin Pathol·2008
6-review
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience.
PMID 18349817·Br J Cancer·2008
8-other
Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy.
PMID 17986853·Cancer Biol Ther·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 23525 GOLDEN SPRINGS DR, SUITE A
DIAMOND BAR, CA 91765 - Phone
- (909) 861-6828
Quick Facts
- NPI
- 1326196114
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile